Manmeet Ahluwalia

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Anheart Therapeutics
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Theraguix
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Menarini Ricerche
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sumitomo Pharma Oncology
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Cairn Therapeutics
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pyramid Biosciences
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Modifi biosciences
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bugworks
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Mimivax
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Cytodyn
    Date added:
    08/08/2023
    Date updated:
    08/08/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond